Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Dehm

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Endocrine-Related Cancer|July 19, 2021
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancerMark Daniel, Todd P Knutson, Jamie M Sperger, et al.
The Prostate|July 17, 2018
Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survivalDawei Li, Guimei Tian, Jia Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Exploitation of CD133 for the Targeted Imaging of Lethal Prostate CancerPaige M Glumac, Joseph P Gallant, Mariya Shapovalova, et al.
Oncotarget|February 12, 2015
EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancerLucas J Brand, Margaret E Olson, Preethi Ravindranathan, et al.
Cancer Letters|February 8, 2021
Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapyTianfang Ma, Shanshan Bai, Yanfeng Qi, et al.
Cancer Research|October 1, 2009
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81Sook Shin, Tae-Dong Kim, Fang Jin, et al.
Scientific Reports|September 28, 2020
SV-HotSpot: detection and visualization of hotspots targeted by structural variants associated with gene expressionAbdallah M Eteleeb, David A Quigley, Shuang G Zhao, et al.
The Prostate|February 2, 2017
Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice VariantsSumit Isharwal, Shrey Modi, Nivedita Arora, et al.
Cancers|October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2023
Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modelingWeijie Zhang, Adam M Lee, Sampreeti Jena, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Endocrine-Related Cancer|July 19, 2021
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancerMark Daniel, Todd P Knutson, Jamie M Sperger, et al.
The Prostate|July 17, 2018
Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survivalDawei Li, Guimei Tian, Jia Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Exploitation of CD133 for the Targeted Imaging of Lethal Prostate CancerPaige M Glumac, Joseph P Gallant, Mariya Shapovalova, et al.
Oncotarget|February 12, 2015
EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancerLucas J Brand, Margaret E Olson, Preethi Ravindranathan, et al.
Cancer Letters|February 8, 2021
Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapyTianfang Ma, Shanshan Bai, Yanfeng Qi, et al.
Cancer Research|October 1, 2009
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81Sook Shin, Tae-Dong Kim, Fang Jin, et al.
Scientific Reports|September 28, 2020
SV-HotSpot: detection and visualization of hotspots targeted by structural variants associated with gene expressionAbdallah M Eteleeb, David A Quigley, Shuang G Zhao, et al.
The Prostate|February 2, 2017
Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice VariantsSumit Isharwal, Shrey Modi, Nivedita Arora, et al.
Cancers|October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2023
Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modelingWeijie Zhang, Adam M Lee, Sampreeti Jena, et al.
Pageof 13